Key result
SVG PCI linked to ~73% greater 1-year MACE risk vs. native coronary PCI.
Why the study?
Data are limited regarding the outcomes of native coronary artery PCI versus saphenous vein graft PCI after prior coronary artery bypass graft surgery.
Does saphenous vein graft PCI increase the risk of MACE compared to native coronary artery PCI in patients with prior CABG?
Cohort (n=401)
No
Does saphenous vein graft PCI increase the risk of MACE compared to native coronary artery PCI in patients with prior CABG?
Answers are grounded in this paper and cite their sources.
In patients with prior CABG, PCI of saphenous vein grafts is associated with a significantly higher 1-year risk of MACE compared to PCI of native coronary arteries, driven by MI and repeat revascularization.
BACKGROUND: Patients with prior coronary artery bypass graft (CABG) surgery often require percutaneous coronary intervention (PCI). Data are still limited in regards to the outcomes of native saphenous vein graft (SVG) PCI after CABG. METHODS: We performed a retrospective study in a tertiary reference cardiac center of consecutive patients who underwent PCI after CABG. The data were collected for patients who underwent either native or graft PCI from January 2008 to December 2018. Arterial graft PCIs were excluded. Multivariable Cox regression analysis with propensity matching was performed, and major adverse cardiac events (MACE) outcomes including death or myocardial infarction (MI) or revascularization were assessed at 1-year after each index procedure. RESULTS: A total of 435 PCI were performed in 401 patients (209 had native PCI and 192 had graft PCI). Target lesions were classified as following: 235 (54%) native coronary arteries and 200 (46%) SVG. Propensity matching resulted in 167 matched pairs. In multivariable Cox regression graft PCI relative to native PCI was an independent risk factor for MACE (hazard ratio [HR] 1.725, 95% confidence interval [CI] 1.049-2.837) which was primarily driven by increased incidence in revascularization (HR 2.218, 95% CI 1.193-4.122) and MI (HR 2.248, 95% CI 1.220-4.142) and with no significant difference in mortality (HR 1.118, 95% CI 0.435-2.870). CONCLUSIONS: Compared with native coronary PCI, bypass graft PCI was significantly associated with higher incidence of MACE at 1-year and this was mainly driven by MI and revascularization.
No takes yet. Share an insight, caveat, or question.
Abdelrahman et al. (2020) conducted a cohort in Prior coronary artery bypass graft (CABG) surgery requiring percutaneous coronary intervention (n=401). Saphenous vein graft (SVG) PCI vs. Native coronary artery PCI was evaluated on 1-year major adverse cardiac events (MACE) defined as a composite of death, myocardial infarction, or target vessel revascularization (HR 1.725, 95% CI 1.049-2.837, p=0.032). Saphenous vein graft PCI was significantly associated with a higher incidence of major adverse cardiac events at 1 year compared to native coronary PCI (HR 1.725).
Synapse has enriched 10 related papers. Consider them for comparative context: